NURS 6630N Final Exam
NURS 6630N Week 11 FINAL EXAM
NURS-6630N: Psychopharmacologic Approaches
to Treatment of Psychopathology.
Latest New Versions
76 Q & A in Each Version, Verified and 100 % Correct|
Best document for Exam
Absolute Satisfaction
, Question 1
0 out of 1 points
A patient diagnosed with obsessive compulsive disorder has been
taking a high-dose SSRI and is participating in therapy twice a week.
He reports an inability to carry out responsibilities due to consistent
interferences of his obsessions and compulsions. The PMHNP knows
that the next step would be which of the following?
Selected Answer: B.
Decrease his SSRI and add an MAOI.
Question 2
0 out of 1 points
Which statement best describes a pharmacological approach to treating
patients for impulsive aggression?
Selected B.
Answer: Atypical antipsychotics can increase subcortical
dopaminergic stimulation.
Question 3
1 out of 1 points
The PMHNP evaluates a patient presenting with symptoms of
dementia. Before the PMHNP considers treatment options, the patient
must be assessed for other possible causes of dementia. Which of the
following answers addresses both possible other causes of dementia
and a rational treatment option for Dementia?
Selected B.
Answer: Possible other causes: hypothyroidism, adrenal
insufficiency, hyperparathyroidism
, Possible treatment option: donepezil
Question 4
1 out of 1 points
An 80-year-old female patient diagnosed with Stage II Alzheimer’s has
a history of irritable bowel syndrome. Which cholinergic drug may be
the best choice for treatment given the patient’s gastrointestinal
problems?
Selected Answer: A.
Donepezil (Aricept)
Question 5
0 out of 1 points
The PMHNP is teaching parents about their child’s new prescription
for Ritalin. What will the PMHNP include in the teaching?
Selected Answer: D.
There will be continued effects into the evening.
Question 6
1 out of 1 points
The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic
pain. How does the PMHNP anticipate the drug to work?
Selected A.
Answer: It will bind to the alpha-2-delta ligand subunit of
voltage-sensitive calcium channels.
Question 7
NURS 6630N Week 11 FINAL EXAM
NURS-6630N: Psychopharmacologic Approaches
to Treatment of Psychopathology.
Latest New Versions
76 Q & A in Each Version, Verified and 100 % Correct|
Best document for Exam
Absolute Satisfaction
, Question 1
0 out of 1 points
A patient diagnosed with obsessive compulsive disorder has been
taking a high-dose SSRI and is participating in therapy twice a week.
He reports an inability to carry out responsibilities due to consistent
interferences of his obsessions and compulsions. The PMHNP knows
that the next step would be which of the following?
Selected Answer: B.
Decrease his SSRI and add an MAOI.
Question 2
0 out of 1 points
Which statement best describes a pharmacological approach to treating
patients for impulsive aggression?
Selected B.
Answer: Atypical antipsychotics can increase subcortical
dopaminergic stimulation.
Question 3
1 out of 1 points
The PMHNP evaluates a patient presenting with symptoms of
dementia. Before the PMHNP considers treatment options, the patient
must be assessed for other possible causes of dementia. Which of the
following answers addresses both possible other causes of dementia
and a rational treatment option for Dementia?
Selected B.
Answer: Possible other causes: hypothyroidism, adrenal
insufficiency, hyperparathyroidism
, Possible treatment option: donepezil
Question 4
1 out of 1 points
An 80-year-old female patient diagnosed with Stage II Alzheimer’s has
a history of irritable bowel syndrome. Which cholinergic drug may be
the best choice for treatment given the patient’s gastrointestinal
problems?
Selected Answer: A.
Donepezil (Aricept)
Question 5
0 out of 1 points
The PMHNP is teaching parents about their child’s new prescription
for Ritalin. What will the PMHNP include in the teaching?
Selected Answer: D.
There will be continued effects into the evening.
Question 6
1 out of 1 points
The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic
pain. How does the PMHNP anticipate the drug to work?
Selected A.
Answer: It will bind to the alpha-2-delta ligand subunit of
voltage-sensitive calcium channels.
Question 7
